“Rite Aid earlier this month quietly rejected a takeover bid that valued the drugstore chain at more than $800 million — despite it being nearly twice the drugstore chain’s current stock price, The Post has learned.
Private-equity firm Spear Point Capital Management said it made an offer to buy Rite Aid on March 30 for $14.60 a share, or $815 million — a 56% premium to its closing price that day of $9.36, Spear Point co-founder Ron Bienvenu told The Post in an exclusive interview”.
Looks like Spear Point is going after Rite Aid's data – ” Spear Point also believes Rite Aid could be making much more by selling its data to other business — including selling its prescription data to insurers — for more than $1 billion. Presently, Rite Aid only shares data with its suppliers to manage inventory, Bienvenu said”.
If companies are undertutilizing their datasets, could data arbitrage be a way to unlock lots of value?
Leave a Reply